JG

Jayeshkumar Gandalal Patel

Director Director DIN 08445057
DIN 08445057 First appointment May 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayeshkumar Gandalal Patel

Data last updated:

Jayeshkumar Gandalal Patel was a Director at Apister Lifesciences Private Limited (2019–2025) and Designated Partner at Solaris Pharmatech Llp (2023). The companies operate in Pharma and Paper.

DIN 08445057
Primary Designation Director
Industry Pharma
First Appointment 08 May 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apister Lifesciences Private Limited U24304GJ2017PTC097161
Director08 May 20192017₹73.56 Cr (FY 2025)Active
Designated Partner11 Jul 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apister Lifesciences Private Limited
Solaris Pharmatech Llp
Premium access

Shareholding and investment profile for Jayeshkumar Gandalal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayeshkumar Gandalal Patel

Jayeshkumar Gandalal Patel was first appointed on 08 May 2019 as Director at Apister Lifesciences Private Limited. The most recent appointment on record is 11 Jul 2023 at Solaris Pharmatech Llp.

Jayeshkumar Gandalal Patel held 2 earlier board appointments: Apister Lifesciences Private Limited (Director, 08 May 2019 to 01 Jan 2025); Solaris Pharmatech Llp (Designated Partner, 11 Jul 2023 to 09 Aug 2023).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available